All Stories

  1. Immune-related biochemical markers and 20-year incidence of atherosclerotic cardiovascular disease: the ATTICA study (2002–2022)
  2. Concordance‐discordance between apolipoprotein B and lipid biomarkers in predicting 20‐year atherosclerotic cardiovascular disease risk: The ATTICA study (2002–2022)
  3. Platelet-Activating Factor-Induced Inflammation in Obesity: A Two-Sided Coin of Protection and Risk
  4. Revisiting the Role of Platelet-Activating Factor in COVID-19-Induced Cardiovascular Complications
  5. Gilthead seabream (Sparus aurata) fed with polar lipids from olive oil industry by-products: Shelf-life, microbiological and physicochemical characteristics during storage at 2 °C
  6. Effect of moderate wine consumption on the activity of enzymes involved in platelet-activating factor metabolism and thrombotic biomarkers: a randomised, single-blind, parallel, clinical study in CHD men patients
  7. Winery By-Products In Vitro and In Vivo Effects on Atherothrombotic Markers: Focus on Platelet-Activating Factor
  8. Consumption of a Mediterranean lean fish enriched with platelet-activating factor inhibitors extracted from olive pomace favorably modulates hemostasis and thrombosis in healthy adults with overweight
  9. Deciphering the associations of selenium distribution in serum GPx-3 and selenoprotein P with cardiovascular risk factors in a healthy population with moderate levels of selenium: The ATTICA study
  10. Is Platelet-Activating Factor the Missing Link Between COVID-19 and Atherosclerosis?
  11. Exploring the Effect of Resveratrol, Tyrosol, and Their Derivatives on Platelet-Activating Factor Biosynthesis in U937 Cells
  12. The Impact of Dietary Carbohydrates on Inflammation-Related Cardiovascular Disease Risk: The ATTICA Study (2002–2022)
  13. Resveratrol, Tyrosol and Their Derivatives Inhibit Platelet Activating Factor Biosynthetic Enzymes in Homogenized U-937 Cells
  14. Effect of Spirulina Nigrita® Supplementation on Indices of Exercise-Induced Muscle Damage after Eccentric Protocol of Upper Limbs in Apparently Healthy Volunteers
  15. Does Yogurt Enriched with Platelet-Activating Factor Inhibitors from Olive Oil By-Products Affect Gut Microbiota and Faecal Metabolites in Healthy Overweight Subjects? (A randomized, parallel, three arm trial.)
  16. Discrimination and net-reclassification of cardiovascular disease risk with Lipoprotein(a) levels: The ATTICA study (2002–2022)
  17. Associations of phase angle with platelet-activating factor metabolism and related dietary factors in healthy volunteers
  18. Food Compass Score predicts incident cardiovascular disease: The ATTICA cohort study (2002–2022)
  19. Selenium, Selenoproteins and 10-year Cardiovascular Risk: Results from the ATTICA Study
  20. Food Compass Score and its association with inflammatory markers and homocysteine in cardiovascular disease-free adults: a cross-sectional analysis of the ATTICA epidemiological study
  21. The Involvement of Lipid Mediators in the Mechanisms of Exercise-Induced Muscle Damage
  22. Protective Effect of Olive Oil Microconstituents in Atherosclerosis: Emphasis on PAF Implicated Atherosclerosis Theory
  23. Platelet activating factor: Have we been missing the forest for the trees?
  24. Is there an interplay between the SARS‐CoV ‐2 spike protein and Platelet‐Activating factor?
  25. Consumption of Farmed Fish, Fed with an Olive-Pomace Enriched Diet, and Its Effect on the Inflammatory, Redox, and Platelet-Activating Factor Enzyme Profile of Apparently Healthy Adults: A Double-Blind Randomized Crossover Trial
  26. Consumption of yogurt enriched with polar lipids from olive oil by-products reduces platelet sensitivity against platelet activating factor and inflammatory indices: A randomized, double-blind clinical trial
  27. Sensory evaluation and consumer response of fillets from seabream fed with lipids extracted from olive oil by-products
  28. Association of PAF and its Metabolic Enzymes with GGT and the Fatty Liver Index in Healthy Volunteers
  29. The effect of moderate wine consumption on cytokine secretion by peripheral blood mononuclear cells: A randomized clinical study in coronary heart disease patients
  30. Antithrombotic properties of differently fed farmed gilthead sea bream: In vitro and in vivo studies
  31. Activities of platelet-activating factor (PAF) enzymes after daily consumption for two months of a yogurt enriched with natural origin PAF inhibitors
  32. Consumption of Enriched Yogurt with PAF Inhibitors from Olive Pomace Affects the Major Enzymes of PAF Metabolism: A Randomized, Double Blind, Three Arm Trial
  33. Mediterranean diet is inversely associated with steatosis and fibrosis and decreases ten-year diabetes and cardiovascular risk in NAFLD subjects: Results from the ATTICA prospective cohort study
  34. Micronutrients, Phytochemicals and Mediterranean Diet: A Potential Protective Role against COVID-19 through Modulation of PAF Actions and Metabolism
  35. Effect of Differently Fed Farmed Gilthead Sea Bream Consumption on Platelet Aggregation and Circulating Haemostatic Markers among Apparently Healthy Adults: A Double-Blind Randomized Crossover Trial
  36. Can Exercise-Induced Muscle Damage Be a Good Model for the Investigation of the Anti-Inflammatory Properties of Diet in Humans?
  37. Associations between red blood cells fatty acids, desaturases indices and metabolism of platelet activating factor in healthy volunteers
  38. COVID‐19, microthromboses, inflammation, and platelet activating factor
  39. The French paradox three decades later: Role of inflammation and thrombosis
  40. Coronavirus 2019, Microthromboses, and Platelet Activating Factor
  41. Changes of rate of torque development in soccer players after a Loughborough Intermittent Shuttle Test: Effect of bovine colostrum supplementation
  42. Cardioprotective properties of a novel enriched yogurt with inhibitors of Platelet Activating Factor (PAF)
  43. Mediterranean diet and the postprandial state: A focus on inflammation, endothelial dysfunction, and hemostasis
  44. Cardioprotective properties of fish enriched with bioactive lipids from olive oil by products
  45. Anti-platelet and anti-inflammatory properties of an ethanol-water red grape pomace extract
  46. Gut microbiome characteristics at the crossroads of metabolic health and lifestyle patterns in an adult population
  47. Mining possible associations of faecal A. muciniphila colonisation patterns with host adiposity and cardiometabolic markers in an adult population
  48. Energy Intake and Plasma Adiponectin as Potential Determinants of Lipoprotein‐Associated Phospholipase A2Activity: A Cross‐Sectional Study
  49. Effects of nut and seed consumption on markers of glucose metabolism in adults with prediabetes: a systematic review of randomised controlled trials
  50. Consumption of plant extract supplement reduces platelet activating factor-induced platelet aggregation and increases platelet activating factor catabolism: a randomised, double-blind and placebo-controlled trial
  51. Yogurt enriched with a natural extract rich in PAF inhibitors and polyphenols. Study design and rationale of a randomized, double blinded, placebo-controlled, parallel intervention study
  52. Evaluation of anti-platelet activity of grape pomace extracts
  53. Mediterranean diet and platelet-activating factor; a systematic review
  54. Suppression of DNA/RNA and protein oxidation by dietary supplement which contains plant extracts and vitamins: a randomized, double-blind, placebo-controlled trial
  55. Biomarkers and Gene Polymorphisms in Members of Long- and Short-lived Families: A Longevity Study
  56. Wine and its metabolic effects. A comprehensive review of clinical trials
  57. Fish consumption and cardiovascular disease related biomarkers: A review of clinical trials
  58. Amino acid profile and metabolic syndrome in a male Mediterranean population: A cross-sectional study
  59. Adherence to the Mediterranean diet is associated with the gut microbiota pattern and gastrointestinal characteristics in an adult population
  60. Influence of Genes on the Lifespan of Long- and Short-Lived Families
  61. Postprandial effects of wine consumption on Platelet Activating Factor metabolic enzymes
  62. Anti-platelet effects of anti-glaucomatous eye drops: an in vitro study on human platelets
  63. A low-dose, 6-week bovine colostrum supplementation maintains performance and attenuates inflammatory indices following a Loughborough Intermittent Shuttle Test in soccer players
  64. Ιn Vivo Effects of Tenofovir-DF/Emtricitabine and Abacavir/Lamivudine with Atazanavir-R on Platelet Activating Factor Metabolism in HIV Naive Patients
  65. Reduced circulating adiponectin levels are associated with the metabolic syndrome independently of obesity, lipid indices and serum insulin levels: a cross-sectional study
  66. Wine consumption reduced postprandial platelet sensitivity against platelet activating factor in healthy men
  67. Hierarchical modelling of blood lipids’ profile and 10-year (2002–2012) all cause mortality and incidence of cardiovascular disease: the ATTICA study
  68. Cave Cyanobacteria showing antibacterial activity
  69. Platelet Activating Factor (PAF) biosynthesis is inhibited by phenolic compounds in U-937 cells under inflammatory conditions
  70. In vitro assessment of antioxidant activity of tyrosol, resveratrol and their acetylated derivatives
  71. Mediterranean Diet and the Postprandial State
  72. Effect of Robola and Cabernet Sauvignon extracts on platelet activating factor enzymes activity on U937 cells
  73. Gender-specific distribution of selenium to serum selenoproteins: Associations with total selenium levels, age, smoking, body mass index, and physical activity
  74. In vivo effect of two first-line ART regimens on inflammatory mediators in male HIV patients
  75. The relation of diet with PAF and its metabolic enzymes in healthy volunteers
  76. Interleukin-1beta stimulates platelet-activating factor production in U-937 cells modulating both its biosynthetic and catabolic enzymes
  77. Platelet Activating Factor in Heart Failure: Potential Role in Disease Progression and Novel Target for Therapy
  78. Additional benefit in CVD risk indices derived from the consumption of fortified milk when combined with a lifestyle intervention
  79. Baseline and 6-Week Follow-Up Levels of PAF and Activity of Its Metabolic Enzymes in Patients With Heart Failure and Healthy Volunteers—A Pilot Study
  80. Effects of HAART on Platelet-Activating Factor Metabolism in Naive HIV-Infected Patients I: Study of the Tenofovir-DF/Emtricitabine/Efavirenz HAART Regimen
  81. Mediterranean wild plants reduce postprandial platelet aggregation in patients with metabolic syndrome
  82. Effects of Highly Active Antiretroviral Therapy on Platelet Activating Factor Metabolism in Naïve HIV-Infected Patients: II) Study of the Abacavir/Lamivudine/Efavirenz Haart Regimen
  83. Mineral Intake
  84. PAF and its metabolic enzymes in healthy volunteers: Interrelations and correlations with basic characteristics
  85. PAF effects on MCP-1 and IL-6 secretion in U-937 monocytes in comparison with OxLDL and IL-1β effects
  86. Platelet-Activating Factor and Its Basic Metabolic Enzymes in Blood of Naive HIV-Infected Patients
  87. Atherosclerosis regression study in rabbits upon olive pomace polar lipid extract administration
  88. High-throughput quantification of selenium in individual serum proteins from a healthy human population using HPLC on-line with isotope dilution inductively coupled plasma-MS
  89. In Vitro and In Vivo Effects of Statins on Platelet-Activating Factor and Its Metabolism
  90. Acute resistance exercise attenuates fasting and postprandial triglyceridemia in women by reducing triglyceride concentrations in triglyceride-rich lipoproteins
  91. Antioxidant and anti-inflammatory activity of red and white wine extracts
  92. Dietary habits of Greek adults and serum total selenium concentration: the ATTICA study
  93. The association between adherence to the Mediterranean diet and adiponectin levels among healthy adults: the ATTICA study
  94. Association of the +45T>G and +276G>T polymorphisms in the adiponectin gene with insulin resistance in nondiabetic Greek women
  95. Dietary antioxidant capacity and concentration of adiponectin in apparently healthy adults: the ATTICA study
  96. N-Terminal ProBNP Distribution and Correlations With Biological Characteristics in Apparently Healthy Greek Population: ATTICA Study
  97. Oral supplementation with l-aspartate and l-glutamate inhibits atherogenesis and fatty liver disease in cholesterol-fed rabbit
  98. Lipoprotein-associated phospholipase A2 (Lp-PLA2) activity, platelet-activating factor acetylhydrolase (PAF-AH) in leukocytes and body composition in healthy adults
  99. Antioxidant and lipoxygenase inhibitory activities of pumpkin seed extracts
  100. Lipid minor constituents in wines. A biochemical approach in the French paradox
  101. Platelet activating factor (PAF) and activity of its biosynthetic and catabolic enzymes in blood and leukocytes of male patients with newly diagnosed heart failure
  102. Serum Total Selenium Status in Greek Adults and Its Relation to Age. The ATTICA Study Cohort
  103. Anti-Platelet-Activating Factor Effects of Highly Active Antiretroviral Therapy (HAART): A New Insight in the Drug Therapy of HIV Infection?
  104. BIOACTIVE POLAR LIPIDS IN OLIVE OIL, POMACE AND WASTE BYPRODUCTS
  105. Chemical Composition of Greek Avgotaracho Prepared from Mullet (Mugil cephalus): Nutritional and Health Benefits
  106. Intravenous infusion of PAF affects ovulation, fertilization and preimplantation embryonic development in NZB x NZW F1 hybrid mice
  107. Dietary choline and betaine intakes in relation to concentrations of inflammatory markers in healthy adults: the ATTICA study
  108. Development, reliability and validity of a new motorized isometric dynamometer for measuring strength characteristics of elbow flexor muscles
  109. Boiled wild artichoke reduces postprandial glycemic and insulinemic responses in normal subjects but has no effect on metabolic syndrome patients
  110. Food Ingredients and Lipid Mediators
  111. Effect of Fast-Food Mediterranean-Type Diet on Human Plasma Oxidation
  112. IL-1β induces a rapid and transient increase of intracellular platelet activating factor in a human mesangial cell line—Modulation by an olive oil polar lipid extract
  113. Antithrombotic and Antiatherosclerotic Properties of Olive Oil and Olive Pomace Polar Extracts in Rabbits
  114. Biological Activity of Acetylated Phenolic Compounds
  115. Characterization of the De Novo Biosynthetic Enzyme of Platelet Activating Factor, DDT-Insensitive Cholinephosphotransferase, of Human Mesangial Cells
  116. Isolation and identification of hydroxyl–platelet-activating factor from natural sources
  117. Effect of Traditional Greek Mediterranean Meals on Platelet Aggregation in Normal Subjects and in Patients with Type 2 Diabetes Mellitus
  118. Platelet-activating factor (PAF) increase intracellular lipid accumulation by increasing both LDL and scavenger receptors in human mesangial cells
  119. Effect of fast-food Mediterranean-type diet on type 2 diabetics and healthy human subjects’ platelet aggregation
  120. In vivo antiatherogenic properties of olive oil and its constituent lipid classes in hyperlipidemic rabbits
  121. Effects of baseline serum levels of Se on markers of eccentric exercise-induced muscle injury
  122. Synthesis and biological evaluation of novel steroid-modified ether phospholipids
  123. Bioactive polar lipids from Chroococcidiopsis sp. (Cyanobacteria)
  124. Understanding local Mediterranean diets: A multidisciplinary pharmacological and ethnobotanical approach
  125. Effects of eccentric exercise-induced muscle injury on blood levels of platelet activating factor (PAF) and other inflammatory markers
  126. Characterization of bioactive glycolipids from Scytonema julianum (cyanobacteria)
  127. Platelet activating factor— a molecular link between atherosclerosis theories
  128. Structure elucidation of phenolic compounds from red/white wine with antiatherogenic properties
  129. Hydroxyl-platelet-activating factor exists in blood of healthy volunteers and periodontal patients
  130. Isolation and structural elucidation of biologically active phospholipids from Scytonema julianum (cyanobacteria)
  131. Oleuropein Inhibits LDL Oxidation Induced by Cooking Oil Frying By-products and Platelet Aggregation Induced by Platelet-Activating Factor
  132. SEPARATION OF POLAR LIPIDS FROM SOYBEAN OIL AND COTTON SEED OIL BY ONE-STEP HPLC SYSTEM. BIOLOGICAL ACTIVITY OF ISOLATED LIPIDS
  133. Biologically Active Lipids with Antiatherogenic Properties from White Wine and Must
  134. Antithrombotic Lipid Minor Constituents from Vegetable Oils. Comparison between Olive Oils and Others
  135. Is Platelet-Activating Factor Produced during Hemodialysis with AN-69 Polyacrylonitrile Membrane?
  136. Separation of Biologically Active Lipids from Red Wine
  137. Biologically active lipids from olive oil with antiatherogenetic action
  138. DETERMINATION OF PLATELET-ACTIVATING FACTOR BY HPLC WITH FLUORESCENCE DETECTION
  139. Identification of a new endogenous platelet-activating factor-like molecule in gingival crevicular fluid
  140. Synthesis of a new phosphoglycolipid with biological activity towards platelets
  141. Identification and Study of Gangliosides from Scomber scombrus Muscle
  142. Separation of Several Main Glycolipids into Classes and Partially into Species by HPLC and UV-Detection
  143. Isolation and Complete Separation of Lipids From Natural Sources
  144. Blood cardiolipin in haemodialysis patients. Its implication in the biological action of platelet-activating factor
  145. Platelet-Activating Factor (PAF) Antagonists in Foods:  A Study of Lipids with PAF or Anti-PAF-like Activity in Cow's Milk and Yogurt
  146. Platelet-Activating Factor Levels and PAF Acetylhydrolase Activities in Patients with Primary Glomerulonephritis
  147. Implication of PAF and Acetylhydrolase (PAF-AH) Activity in Periodontal Disease
  148. Biologically Active Lipids from S. Scombrus
  149. A Discovery Trip to Compounds with PAF-Like Activity
  150. Lipid Separation from Urtica dioica:  Existence of Platelet-Activating Factor
  151. The Production of Platelet-Activating Factor (PAF) during Hemodialysis with Cuprophane Membrane. Does the Calcium Concentration in the Dialysate Play Any Role on It?
  152. Platelet-activating factor acetylhydrolase (PAF-AH) in human kidney
  153. Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated
  154. A simple and precise method for the routine determination of platelet-activating factor in blood and urine
  155. Separation of the Main Neutral Lipids into Classes and Species by PR-HPLC and UV Detection